Skip to main content

LP Dwoskin

First name:
LP
Last name:
Dwoskin
Butt, C. ., , Wilkins, L. ., Dwoskin, L. ., & Debski, E. . Pharmacology, distribution and development of muscarinic acetylcholine receptor subtypes in the optic tectum of Rana pipiens. Neuroscience, 104(1), 161-79. https://doi.org/10.1016/s0306-4522(01)00048-3 (Original work published 2001)
Beckmann, J. ., Denehy, E. ., Zheng, G. ., Crooks, P. ., Dwoskin, L. ., & Bardo, M. . (2012). The effect of a novel VMAT2 inhibitor, GZ-793A, on methamphetamine reward in rats. Psychopharmacology, 220(2), 395-403. https://doi.org/10.1007/s00213-011-2488-9
Wooters, T. ., Dwoskin, L. ., & Bardo, M. . (2011). Discriminative stimulus effects of NMDA, AMPA, and mGluR5 glutamate receptor ligands in methamphetamine-trained rats. Behavioural Pharmacology, 22(5-6), 516-24. https://doi.org/10.1097/FBP.0b013e328349aafa
Dwoskin, L. ., & Bardo, M. . (2009). Targeting nicotinic receptor antagonists as novel pharmacotherapies for tobacco dependence and relapse. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology, 34(1), 244-6. https://doi.org/10.1038/npp.2008.157
Meyer, A. ., Rahman, S. ., Charnigo, R. ., Dwoskin, L. ., Crabbe, J. ., & Bardo, M. . (2010). Genetics of novelty seeking, amphetamine self-administration and reinstatement using inbred rats. Genes, Brain, and Behavior, 9(7), 790-8. https://doi.org/10.1111/j.1601-183X.2010.00616.x
Beckmann, J. ., Siripurapu, K. ., , Horton, D. ., Denehy, E. ., Vartak, A. ., … Bardo, M. . (2010). The novel pyrrolidine nor-lobelane analog UKCP-110 cis-2,5-di-(2-phenethyl)-pyrrolidine hydrochloride inhibits VMAT2 function, methamphetamine-evoked dopamine release, and methamphetamine self-administration in rats. The Journal of Pharmacology and Experimental Therapeutics, 335(3), 841-51. https://doi.org/10.1124/jpet.110.172742
Perry, J. ., Joseph, J. ., Jiang, Y. ., Zimmerman, R. ., Kelly, T. ., Darna, M. ., … Bardo, M. . (2011). Prefrontal cortex and drug abuse vulnerability: translation to prevention and treatment interventions. Brain Research Reviews, 65(2), 124-49. https://doi.org/10.1016/j.brainresrev.2010.09.001 (Original work published 2011)
Horton, D. ., Siripurapu, K. ., Norrholm, S. ., Culver, J. ., Hojahmat, M. ., Beckmann, J. ., … Dwoskin, L. . (2011). meso-Transdiene analogs inhibit vesicular monoamine transporter-2 function and methamphetamine-evoked dopamine release. The Journal of Pharmacology and Experimental Therapeutics, 336(3), 940-51. https://doi.org/10.1124/jpet.110.175117
Wooters, T. ., Bardo, M. ., Dwoskin, L. ., Midde, N. ., Gomez, A. ., Mactutus, C. ., … Zhu, J. . (2011). Effect of environmental enrichment on methylphenidate-induced locomotion and dopamine transporter dynamics. Behavioural Brain Research, 219(1), 98-107. https://doi.org/10.1016/j.bbr.2011.01.001 (Original work published 2011)
Wooters, T. ., Smith, A. ., Pivavarchyk, M. ., Siripurapu, K. ., McIntosh, J. ., Zhang, Z. ., … Dwoskin, L. . (2011). bPiDI: a novel selective α6β2* nicotinic receptor antagonist and preclinical candidate treatment for nicotine abuse. British Journal of Pharmacology, 163(2), 346-57. https://doi.org/10.1111/j.1476-5381.2011.01220.x